EP Patent

EP1708708A1 — Montelukast free acid polymorphs

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2006-10-11 · 20y expired

What this patent protects

The present invention relates to amorphous and polymorphic forms of montelukast free acid.

USPTO Abstract

The present invention relates to amorphous and polymorphic forms of montelukast free acid.

Drugs covered by this patent

Patent Metadata

Patent number
EP1708708A1
Jurisdiction
EP
Classification
—
Expires
2006-10-11
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.